New Delhi: The National Pharmaceutical Pricing Authority (NPPA), while considering an application submitted by Biodeal Pharmaceuticals Limited seeking exemption from the provisions of the Drugs (Prices Control) Order, 2013 (DPCO, 2013) under Para 32(iii) for the formulation "Midazolam Nasal Spray 1.25% w/v", has decided to seek inputs from the Central Drugs Standard Control Organization (CDSCO) and the Standing National Committee on Medicines (SNCM) before taking a final decision on the matter.

The recommendation came during the 71st meeting of the Multidisciplinary Committee of Experts held on 16.09.2025, where the committee reviewed the application by Biodeal Pharmaceuticals Limited for exemption from the provisions of Drug Price Control Order 2013 under Para 32 (iii) for the formulati

See Full Page